| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/02656730903369200 |
| P698 | PubMed publication ID | 20146566 |
| P50 | author | Christina Fotopoulou | Q38296199 |
| Jalid Sehouli | Q40942564 | ||
| P2093 | author name string | Peter Wust | |
| Johanna Gellermann | |||
| Werner Lichtenegger | |||
| Chie Hee Cho | |||
| Robert Kraetschell | |||
| P2860 | cites work | A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer | Q33337475 |
| Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study | Q33382309 | ||
| Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational study | Q33382867 | ||
| Effect of whole body hyperthermia on carboplatin disposition and toxicity in dogs | Q33490630 | ||
| Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients | Q33490971 | ||
| Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel | Q33503973 | ||
| Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy | Q33879026 | ||
| Characterization of mild whole-body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice | Q35615128 | ||
| Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow | Q35993812 | ||
| Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany. | Q36804777 | ||
| The efficacy of caelyx and hyperthermia for anticancer treatment | Q37067038 | ||
| Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin | Q37649484 | ||
| Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens | Q40865814 | ||
| Thermal enhancement of tetraplatin and carboplatin in human leukaemic cells | Q41715299 | ||
| Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. | Q44854390 | ||
| Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. | Q45976411 | ||
| Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology | Q46142079 | ||
| Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. | Q46792064 | ||
| Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis | Q46932131 | ||
| Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin | Q48544540 | ||
| Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators. | Q52917228 | ||
| Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. | Q53571926 | ||
| Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer. | Q53897241 | ||
| Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer. | Q53972578 | ||
| Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine. | Q54318551 | ||
| P433 | issue | 2 | |
| P921 | main subject | ovarian cancer | Q172341 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 118-126 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | International Journal of Hyperthermia | Q332272 |
| P1476 | title | Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study | |
| P478 | volume | 26 |
| Q37708922 | In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia |
| Q38656720 | Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary? |
| Q93357251 | Oncological hyperthermia: The correct dosing in clinical applications |
| Q36238725 | Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements |
| Q41772742 | Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis |
| Q96127396 | Relationship between Energy Dosage and Apoptotic Cell Death by Modulated Electro-Hyperthermia |
| Q33575508 | Targeted Intracellular Heat Transfer in Cancer Therapy: Assessment of Asparagine-laminated Gold Nanoparticles in Cell Model of T cell Leukemia |
| Q36647178 | The effect of modulated electro-hyperthermia on the pharmacokinetic properties of nefopam in healthy volunteers: A randomised, single-dose, crossover open-label study |
| Q28388114 | The role of mitochondria-derived reactive oxygen species in hyperthermia-induced platelet apoptosis |
| Q64232827 | Ultrasound Hyperthermia Technology for Radiosensitization |
| Q38012536 | Ultrasound-induced cell permeabilisation and hyperthermia: strategies for local delivery of compounds with intracellular mode of action |
Search more.